30/10/2025
gives new hope to the locally advanced patient with obstruction and . Prof. Jian Chen first performs nutritional catheter placement, then administers arterial infusion chemotherapy combined with immunotherapy, letting the tumor almost completely regress . By using this therapy, the surgical conversion rate currently reaches nearly 70%, and patients' survival rates are far higher than those with conventional chemotherapy.